 |
PDBsum entry 5iee
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain A:
E.C.3.2.1.207
- mannosyl-oligosaccharide alpha-1,3-glucosidase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
N4-(alpha-D-Glc-(1->3)-alpha-D-Glc-(1->3)-alpha-D-Man-(1->2)-alpha- D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)- [alpha-D-Man-(1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man- (1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc)-L-asparaginyl-[protein] + H2O = N4-(alpha-D-Glc-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)- alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man- (1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D- GlcNAc-(1->4)-beta-D-GlcNAc)-L-asparaginyl-[protein] + beta-D-glucose
|
|
2.
|
N4-(alpha-D-Glc-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha- D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)- alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc- (1->4)-beta-D-GlcNAc)-L-asparaginyl-[protein] + H2O = N4-(alpha-D-Man- (1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D- Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6CC -!- This eukaryotic enzyme cleaves off sequentially the two alpha-1,3-
|
|
 |
 |
 |
 |
 |
N(4)-(alpha-D-Glc-(1->3)-alpha-D-Glc-(1->3)-alpha-D-Man-(1->2)-alpha- D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)- [alpha-D-Man-(1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man- (1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc)-L-asparaginyl-[protein]
|
+
|
H2O
|
=
|
N(4)-(alpha-D-Glc-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)- alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man- (1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D- GlcNAc-(1->4)-beta-D-GlcNAc)-L-asparaginyl-[protein]
Bound ligand (Het Group name = )
matches with 62.50% similarity
|
+
|
beta-D-glucose
|
|
 |
 |
 |
 |
 |
N(4)-(alpha-D-Glc-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha- D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)- alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc- (1->4)-beta-D-GlcNAc)-L-asparaginyl-[protein]
|
+
|
H2O
|
=
|
N(4)-(alpha-D-Man- (1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D- Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6CC -!- This eukaryotic enzyme cleaves off sequentially the two alpha-1,3-
Bound ligand (Het Group name = )
matches with 62.50% similarity
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
113:E4630
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structures of mammalian ER α-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals.
|
|
A.T.Caputo,
D.S.Alonzi,
L.Marti,
I.B.Reca,
J.L.Kiappes,
W.B.Struwe,
A.Cross,
S.Basu,
E.D.Lowe,
B.Darlot,
A.Santino,
P.Roversi,
N.Zitzmann.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The biosynthesis of enveloped viruses depends heavily on the host cell
endoplasmic reticulum (ER) glycoprotein quality control (QC) machinery. This
dependency exceeds the dependency of host glycoproteins, offering a window for
the targeting of ERQC for the development of broad-spectrum antivirals. We
determined small-angle X-ray scattering (SAXS) and crystal structures of the
main ERQC enzyme, ER α-glucosidase II (α-GluII; from mouse), alone and in
complex with key ligands of its catalytic cycle and antiviral iminosugars,
including two that are in clinical trials for the treatment of dengue fever. The
SAXS data capture the enzyme's quaternary structure and suggest a conformational
rearrangement is needed for the simultaneous binding of a monoglucosylated
glycan to both subunits. The X-ray structures with key catalytic cycle
intermediates highlight that an insertion between the +1 and +2 subsites
contributes to the enzyme's activity and substrate specificity, and reveal that
the presence of d-mannose at the +1 subsite renders the acid catalyst less
efficient during the cleavage of the monoglucosylated substrate. The complexes
with iminosugar antivirals suggest that inhibitors targeting a conserved ring of
aromatic residues between the α-GluII +1 and +2 subsites would have increased
potency and selectivity, thus providing a template for further rational drug
design.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|